(Q40022085)

English

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels?

scientific article published on November 1, 1976

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels? (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels? (English)

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

author name string

D. Ganesan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

H. B. Bass

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

W. J. McConathy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

P. Alaupovic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=185483

26 December 2022

publication date

1 November 1976

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0026049576800017?httpAccept=text/xml

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

https://api.elsevier.com/content/article/PII:S0026049576800017?httpAccept=text/plain

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1189-1195

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E-III) in the very-low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Activation of highly purified lipoprotein lipase from bovine milk

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Isolation of C‐I and C‐II activated lipoprotein lipases and protamine insensitive triglyceride lipase by heparin‐sepharose affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Very low density lipoprotein subfractions in a subject with broad-β disease (type III hyperlipoproteinemia) and a subject with endogenous lipemia (type IV) chemical composition and electrophoretic mobility

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Identifiers

10.1016/S0026-0495(76)80001-7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40022085&oldid=1795977381"